TABLE 1.
TCGA-BLCA data set patient baseline data table.
| Characteristic | Levels | Low expression of HSPB8 | High expression of HSPB8 | p |
|---|---|---|---|---|
| n | 207 | 207 | ||
| T stage, n (%) | T1 | 5 (1.3%) | 0 (0%) | 0.013 |
| T2 | 60 (15.8%) | 59 (15.5%) | ||
| T3 | 100 (26.3%) | 96 (25.3%) | ||
| T4 | 21 (5.5%) | 39 (10.3%) | ||
| N stage, n (%) | N0 | 134 (36.2%) | 105 (28.4%) | 0.005 |
| N1 | 17 (4.6%) | 29 (7.8%) | ||
| N2 | 28 (7.6%) | 49 (13.2%) | ||
| N3 | 4 (1.1%) | 4 (1.1%) | ||
| M stage, n (%) | M0 | 110 (51.6%) | 92 (43.2%) | 1.000 |
| M1 | 6 (2.8%) | 5 (2.3%) | ||
| Pathologic stage, n (%) | Stage I | 4 (1%) | 0 (0%) | 0.003 |
| Stage II | 72 (17.5%) | 58 (14.1%) | ||
| Stage III | 77 (18.7%) | 65 (15.8%) | ||
| Stage IV | 53 (12.9%) | 83 (20.1%) | ||
| Gender, n (%) | Female | 53 (12.8%) | 56 (13.5%) | 0.823 |
| Male | 154 (37.2%) | 151 (36.5%) | ||
| Age, meidan (IQR) | 69 (59, 75) | 69 (61, 76.5) | 0.280 |